Everpine Capital

Everpine Capital is a Chinese private equity firm specializing in cross-border investments that enhance growth through entry into the Chinese market. The firm focuses on sectors such as medical devices, industrial technology, education, and consumer goods, aiming to introduce high-quality international technologies, brands, and management resources into China. This includes cutting-edge industrial technology, medical technology, educational innovation, and lifestyle and culture. Everpine Capital is committed to upgrading Chinese industries and accelerating the internationalization of Chinese enterprises.

The firm's investment strategy involves a 'Capital + Industry' and 'International IP + Chinese Market' model, utilizing cross-border mergers and acquisitions combined with localized investments. This approach seeks to bridge the gap between international innovations and the Chinese market, fostering growth and development within China. Everpine Capital maintains a strong network with strategic partners who are leaders in their respective industries in China, facilitating successful market entry and expansion for its portfolio companies.

Everpine Capital's portfolio includes investments in companies such as Eye Tech Care, a French developer of non-invasive ultrasound treatments for glaucoma, and SyberJet Aircraft, an American aircraft manufacturer. These investments reflect the firm's commitment to bringing innovative technologies to the Chinese market, particularly in the medical device and aerospace sectors. The firm's approach emphasizes long-term value creation and strategic growth for its portfolio companies, leveraging its expertise in cross-border investments and deep understanding of the Chinese market.